Integration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study

Integration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study

Saved in:

Bibliographic Details
Main Authors:	Chin An Yang, Sami Teeny, C Christina Mehta, Qian Yang, Tsungirirai Maramba, Igho Ofotokun, Anandi N Sheth, Kristal M Maner-Smith, Mohammed K Ali, Dean P Jones, Young-Mi Go, Thomas R Ziegler, Cecile D Lahiri, Jessica A Alvarez
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Current Developments in Nutrition
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475299125027301
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors
by: Xiaoju Ni, et al.
Published: (2012-01-01)

From protease inhibitors to integrase strand transfer inhibitors: the evolution of HIV drug resistance management
by: HU Zhiliang, YANG Yongfeng
Published: (2025-01-01)

Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors
by: Daniele Armenia, et al.
Published: (2025-06-01)

Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China
by: Huizheng Zhang, et al.
Published: (2023-12-01)

Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors
by: Yen-Wen Chen, et al.
Published: (2020-07-01)

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3′-Processing Suppression
by: Sharif Karim Sayyed, et al.
Published: (2024-12-01)

First Reported Case of Integrase Strand Transfer Inhibitor Resistance in Suriname: Unusual Drug Resistance Mutations Following Exposure to Dolutegravir
by: Rachel C. Sno, et al.
Published: (2025-02-01)

HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocol
by: Vincent Kamaël Mekel, et al.
Published: (2025-04-01)

Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors
by: Yen-Wen Chen, et al.
Published: (2022-01-01)

Sex differences in discontinuations due to side effects of second-generation integrase strand transfer inhibitors: a systematic review and meta-analysisResearch in context
by: Zhou Fang, et al.
Published: (2025-06-01)

Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
by: Sebastiaan O Verboeket, et al.
Published: (2021-01-01)

Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV
by: Giovanni Guaraldi, et al.
Published: (2023-12-01)

Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study
by: Nicola Squillace, et al.
Published: (2025-05-01)

Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study
by: Julien De Greef, et al.
Published: (2025-07-01)

A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75.
by: Stephen Hare, et al.
Published: (2009-01-01)

Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts
by: Thierry Tiendrebeogo, et al.
Published: (2024-12-01)

Lipid abnormality correction by integrase inhibitor among children taking ARt
by: A. V. Samarina, et al.
Published: (2019-10-01)

Analysis of raltegravir analogs to enhance inhibitory efficiency against HIV integrase
by: Hanieh Sabaghian, et al.
Published: (2025-05-01)

Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis.
by: Peter Messiaen, et al.
Published: (2013-01-01)

The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.
by: Alan Engelman, et al.
Published: (2008-03-01)

Development of circular AAV cargos for targeted seamless insertion with large serine integrases
by: Brett J.G. Estes, et al.
Published: (2025-06-01)

Variable orthogonality of serine integrase interactions within the ϕC31 family
by: Alasdair I. MacDonald, et al.
Published: (2024-11-01)

Diabetes mellitus in patients with HIV naïve to antiretroviral therapy initiating integrase inhibitors therapy
by: Sara Dias da Costa, et al.
Published: (2025-07-01)

A history-dependent integrase recorder of plant gene expression with single-cell resolution
by: Cassandra J. Maranas, et al.
Published: (2024-10-01)

Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis.
by: Christiana Smith, et al.
Published: (2023-01-01)

Phage Bxb1 integrase mediates highly efficient site-specific recombination in mammalian cells
by: John P. Russell, et al.
Published: (2006-04-01)

Influence of Strand Size on the Bending Properties of Parallel Strand Bamboo
by: Wenli Zhu, et al.
Published: (2024-12-01)

Influence of Mg2+ ions on the interaction between 3,5-dicaffeoylquinic acid and HTLV-I integrase
by: Orlando Acevedo, et al.
Published: (2012-04-01)

TAR RNA Mimicry of INI1 and Its Influence on Non-Integration Function of HIV-1 Integrase
by: Ganjam V. Kalpana, et al.
Published: (2025-05-01)

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries
by: Davy-Hyacinthe Gouissi Anguechia, et al.
Published: (2024-11-01)

Hypermutability of damaged single-strand DNA formed at double-strand breaks and uncapped telomeres in yeast Saccharomyces cerevisiae.
by: Yong Yang, et al.
Published: (2008-11-01)

From lipid analysis to lipidomics
by: V. A. Akmurzina, et al.
Published: (2012-12-01)

The one-key-to-two-doors role of lipidomics: plasma lipidome, cardiovascular risk and statin usage
by: Anatol Kontush
Published: (2025-05-01)

Utilization of natural products in diverse pathogeneses of diseases associated with single or double DNA strand damage repair
by: Jiali Liang, et al.
Published: (2025-04-01)

Asymmetrical p-stranding
by: Rodrigo Delgado, et al.
Published: (2025-04-01)

Influence of Casting on Two Strands in Three-Strand Tundish on Length of Transient Areas
by: Peter Šmigura, et al.
Published: (2024-09-01)

Excess single-stranded DNA inhibits meiotic double-strand break repair.
by: Rebecca Johnson, et al.
Published: (2007-11-01)

Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study
by: Rao AM, et al.
Published: (2025-07-01)

Insight into the Interaction between the HIV-1 Integrase Inhibitor Elvitegravir and Bovine Serum Albumin: A Spectroscopic Study
by: Ali Saber Abdelhameed
Published: (2015-01-01)

Cytokine concentration and T cell subsets in the female genital tract in the presence of bacterial vaginosis and Trichomonas vaginalis
by: Marisa R. Young, et al.
Published: (2025-04-01)